PHIO – phio pharmaceuticals corp. (US:NASDAQ)
Stock Stats
News
5/15
01:07 pm
phio
Low
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study [Yahoo! Finance]
5/15
01:00 pm
phio
Low
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study
5/14
08:07 am
phio
Medium
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
5/9
05:31 pm
phio
Medium
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update [Yahoo! Finance]
5/9
05:25 pm
phio
Medium
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
5/14
08:07 am
Reiterates
Buy
Buy
HC Wainwright
Medium
4.6%
5/9
05:23 pm
phio
High
Form 8-K Phio Pharmaceuticals For: May 09
5/9
05:21 pm
phio
High
Form 10-Q Phio Pharmaceuticals For: Mar 31
5/8
05:04 pm
phio
Medium
Form DEFA14A Phio Pharmaceuticals
5/8
05:02 pm
phio
Medium
Form DEF 14A Phio Pharmaceuticals For: Jun 17
5/8
05:01 pm
phio
Medium
Form ARS Phio Pharmaceuticals For: Dec 31
Show more
Top News Gainers
11/8 Form 8-K/A Phio Pharmaceuticals For: Oct 24 23.1%
11/13 Form 424B5 Phio Pharmaceuticals 20.3%
10/15 Form DEFA14A Phio Pharmaceuticals 17.1%
11/18 Form 424B3 Phio Pharmaceuticals 15.6%
11/20 Phio Pharmaceuticals Announces Closing of Public Offering of Common Stock 13.1%
1/6 Phio Pharmaceuticals to Present at Biotech Showcase 2020 10.4%
1/15 Phio Pharmaceuticals Corp (NASDAQ: PHIO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 9.2%
11/20 Form 8-K Phio Pharmaceuticals For: Nov 19 9.0%
2/28 Form S-8 Phio Pharmaceuticals 8.4%
12/18 Form 8-K Phio Pharmaceuticals For: Dec 16 8.1%
Top News Decliners
2/11 Phio Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering -55.5%
3/31 Phio Pharmaceuticals Announces $4.0 Million Registered Direct Offering Priced At-the-Market -29.5%
3/11 Phio Pharma up 30% premarket on Medigene deal [Seeking Alpha] -25.1%
11/18 Phio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common Stock -22.9%
11/21 Phio Pharma +51% premarket on expanding collaboration with Karolinska Institutet for RNAi immunotherapies [Seeking Alpha] -15.6%
1/10 Form 8-K Phio Pharmaceuticals For: Jan 10 -13.7%
12/13 Phio Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders -12.8%
11/13 Phio Pharmaceuticals Announces Proposed Public Offering of Common Stock -11.1%
3/26 Q4/2019 12/31/2019 EPS -4.690 ZacksConsensus N/A ActVsEst N/A - N/A -10.6%
2/10 Phio Pharmaceuticals Announces Compliance with Nasdaq Listing Requirements -10.5%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3